These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24602469)

  • 21. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
    Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supratherapeutic doses of angiotensin receptor blockers to decrease proteinuria in patients with chronic kidney disease.
    Palmer BF
    Am J Nephrol; 2008; 28(3):381-90. PubMed ID: 18063856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
    Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
    Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive therapy in the presence of proteinuria.
    Sarafidis PA; Khosla N; Bakris GL
    Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.
    Seeman T; Pohl M; Misselwitz J; John U
    Kidney Blood Press Res; 2009; 32(6):440-4. PubMed ID: 20016211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Principal entity of hypertension version of CKD guide].
    Kimura G
    Nihon Jinzo Gakkai Shi; 2009; 51(4):442-5. PubMed ID: 19601550
    [No Abstract]   [Full Text] [Related]  

  • 28. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P
    Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New concept of chronic kidney disease and blockade of renin-angiotensin system].
    Takeda T; Gejyo F
    Nihon Rinsho; 2007 Sep; 65(9):1727-33. PubMed ID: 17877002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
    Expert Opin Investig Drugs; 2010 Sep; 19(9):1027-37. PubMed ID: 20649501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the management of chronic kidney disease in Uruguay: a National Renal Healthcare Program.
    Schwedt E; Solá L; Ríos PG; Mazzuchi N;
    Nephron Clin Pract; 2010; 114(1):c47-59. PubMed ID: 19816043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How should renin-angiotensin system blockade be applied in chronic kidney disease for optimal renal protection?
    Zhang X; Hou FF
    Chin Med J (Engl); 2007 Feb; 120(3):243-5. PubMed ID: 17355830
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
    Nakamura T; Fujiwara N; Kawagoe Y; Sugaya T; Ueda Y; Koide H
    Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
    Palmer BF
    Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of blood pressure in patients with diabetes.
    Grossman E; Messerli FH
    Am J Hypertens; 2011 Aug; 24(8):863-75. PubMed ID: 21525967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension management in outpatient visits by diabetic patients.
    Aparasu RR; Aparasu A
    Res Social Adm Pharm; 2008 Sep; 4(3):284-91. PubMed ID: 18794038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of hypertension in CKD patients].
    Kusaba T; Kimura K
    Nihon Rinsho; 2008 Sep; 66(9):1747-52. PubMed ID: 18788405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment.
    de Goeij MC; Liem M; de Jager DJ; Voormolen N; Sijpkens YW; Rotmans JI; Boeschoten EW; Dekker FW; Grootendorst DC; Halbesma N;
    Nephron Clin Pract; 2012; 121(1-2):c73-82. PubMed ID: 23128440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: new therapeutic world beyond blood pressure reduction.
    Nakao N; Sakai M; Fujimori A; Fukagawa M
    Kidney Int; 2005 Sep; 68(3):1375-6. PubMed ID: 16105086
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.